Pathophysiological Mechanisms of Hepatopulmonary Influence in the Fontan Circulation

• Status: Completed
• Trial end date: 2007-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Randomisation between postoperative administration of an ACE-inhibitor or not.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Ghent
• Treatments: Angiotensin-Converting Enzyme Inhibitors

Criteria

Inclusion Criteria:

• All consecutive children with a univentricular heart disease undergoing elective surgery for creation of a Fontan circulation

• Parents have agreed with the study after informed consent

Exclusion Criteria:

• Urgent / Emergent surgery

• Preoperative use of an ACE-inhibitor